Prof. Lixin Zhang served as the Director of National Key Laboratory of Bioreactor Engineering at East China University of Science and Technology. His research focused on: Taxonomy guided diversification of a marine microbial natural product library; screening for synergistic medicines in a high throughput manner; increasing the production of drugable secondary metabolites from microbial producers by synthetic biology. His Avermectin project won a National Award for "Excellence to improve science and technologies” in 2017. He was a Chief Scientist of a “973 Program” and an Awardee of the National Science Fund for Distinguished Young Scholars, China. He worked in 3 pharmaceutical companies in USA and published seven books, 288 papers and holds 28 Chinese patents and 16 PCT patents. He served as the President of the International Chemical Biology Society (ICBS) during 2016-8. He has been appointed as an Editor-in-Chief for "Synthetic and Systems Biotechnology", Associate Editor-in-Chief for "Applied Microbiology and Biotechnology", etc. He also served as an Executive Board Member of International Committee on the Biology of Actinomycetes (ISBA) and the GIM (Genetics of Industrial Microorganisms). He is also on the SYNBIOCHEM External Advisory Board for the Manchester Institute of Biotechnology.

Email：lxzhang@ecust.edu.cn

Website：http://biotech.ecust.edu.cn/2016/1019/c7935a56621/page.htm